Pancreatic steatosis demonstrated at MR imaging in the general population: Clinical relevance

Radiology

Volumn 276, Issue 1, 2015, Pages 129-136

  Kühn, Jens Peter ^a   Berthold, Friederike ^a   Mayerle, Julia ^a   Völzke, Henry ^a   Reeder, Scott B ^b   Rathmann, Wolfgang ^c   Lerch, Markus M ^a   Hosten, Norbert ^a   Hegenscheid, Katrin ^a   Meffert, Peter J ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL LIPASE;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ORAL GLUCOSE TOLERANCE TEST; PANCREAS DISEASE; PANCREATIC STEATOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEATOSIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; ADIPOSE TISSUE; AGED; COMPLICATION; MIDDLE AGED; PANCREAS; PATHOLOGY;

ADIPOSE TISSUE; ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREAS; PANCREATIC DISEASES; PREDIABETIC STATE; PROSPECTIVE STUDIES;

EID: 84937033818     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.15140446     Document Type: Article

References (38)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37(12):1595-1607.
2. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition - a consensus statement from the International Diabetes Federation. Diabet Med 2006;23(5):469-480.
3. van Raalte DH, van der Zijl NJ, Diamant M. Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care 2010;13(4):478-485.
4. Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9(2):92-97.
5. Katz DS, Hines J, Math KR, Nardi PM, Mindelzun RE, Lane MJ. Using CT to reveal fat-containing abnormalities of the pancreas. AJR Am J Roentgenol 1999;172(2):393-396.
6. Kühn JP, Hernando D, Muñoz del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265(1):133-142.
7. Reeder SB, Hu HH, Sirlin CB. Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 2012;36(5):1011-1014.
8. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2∗ estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008;60(5):1122-1134.
9. Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011;258(3):767-775.
10. Yokoo T, Shiehmorteza M, Hamilton G, et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011;258(3):749-759.
11. Hu HH, Kim HW, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 2010;18(4):841-847.
12. Lee SE, Jang JY, Lim CS, et al. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann Surg 2010;251(5):932-936.
13. Au WY, Lam WW, Chu W, et al. A T2∗ magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica 2008;93(1):116-119.
14. Noetzli LJ, Papudesi J, Coates TD, Wood JC. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 2009;114(19):4021-4026.
15. Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;37(6):630-639.
16. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011;40(2):294-307.
17. WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser 1980;646:1-80.
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15(7):539-553.
19. Hegenscheid K, Kühn JP, Völzke H, Biffar R, Hosten N, Puls R. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study. Rofo 2009;181(8):748-759.
20. Kühn JP, Evert M, Friedrich N, et al. Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2∗ relaxation effects. Invest Radiol 2011;46(12):783-789.
21. Kühn JP, Jahn C, Hernando D, et al. T1 bias in chemical shift-encoded liver fat-fraction: role of the flip angle. J Magn Reson Imaging 2014;40(4):875-883.
22. Yu H, McKenzie CA, Shimakawa A, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2∗ estimation. J Magn Reson Imaging 2007;26(4):1153-1161.
23. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009;29(6):1332-1339.
24. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007;58(2):354-364.
25. de Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230(3):652-659.
26. Chang JS, Taouli B, Salibi N, Hecht EM, Chin DG, Lee VS. Opposed-phase MRI for fat quantification in fat-water phantoms with 1H MR spectroscopy to resolve ambiguity of fat or water dominance. AJR Am J Roentgenol 2006;187(1):W103-W106.
27. Fischer MA, Gnannt R, Raptis D, et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest Radiol 2011;46(6):351-358.
28. Sauerbrei W, Royston P. Building multi-variable prognostic and diagnostic models: transformation of the predictors by using fractional polynomials. J R Stat Soc Ser A Stat Soc 2002;162(1):71-94.
29. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 2008;43(5):330-337.
30. Sijens PE, Edens MA, Bakker SJL, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010;16(16):1993-1998.
31. Zhong X, Nickel MD, Kannengiesser SA, Dale BM, Kiefer B, Bashir MR. Liver fat quantification using a multi-step adaptive fitting approach with multi-echo GRE imaging. Magn Reson Med 2014;72(5):1353-1365.
32. Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010;26(3):200-205.
33. van der Zijl NJ, Goossens GH, Moors CCM, et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 2011;96(2):459-467.
34. Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS ONE 2013;8(5):e62561.
35. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 2007;20(8):933-942.
36. Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. Cardiovasc Diabetol 2013;12:77.
37. Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009;15(15):1869-1875.
38. Yuan F, Song B, Tang HH, Chen GW, Li J, Xie Y. Quantification of pancreas fat by MRS and FATSAT with 3.0T MRI [in Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban 2010;41(1):145-147, 157.